Quercetin targets VCAM1 to prevent diabetic cerebrovascular endothelial cell injury

Jiebin Huang1, Weiwei Lin2, Yuxing Sun3

  • 1Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

Insights

This study identifies key endothelial cell subtypes and their communication pathways involved in diabetes development. VCAM1, a crucial protein, shows altered expression and may be a therapeutic target for diabetes-related neurodegenerative diseases.

Area of Science:

  • Cardiovascular Biology
  • Endothelial Cell Biology
  • Diabetes Pathophysiology

Background:

  • Endothelial cells are critical in diabetes-related neurodegenerative diseases.
  • Understanding endothelial cell mechanisms in diabetes is essential for therapeutic development.

Purpose of the Study:

  • To investigate the role and mechanisms of endothelial cells in diabetes development.
  • To identify specific endothelial cell subtypes and their interactions in cardiovascular tissues during diabetes progression.

Main Methods:

  • Single-cell RNA sequencing to identify endothelial cell subtypes.
  • Cell-cell communication analysis to map ligand-receptor interactions.
  • Differential gene expression analysis to identify diabetes-related genes.
  • Cell trajectory inference to track developmental changes.
  • Gene Set Enrichment Analysis (GSEA) for functional insights.
  • Molecular dynamics simulations (MDSs) for drug target identification.

Main Results:

  • Identified seven cell types, including five endothelial cell subtypes (EC_1, EC_2, EC_3, EC_4, EC_EndMT) in mouse heart and aorta.
  • Discovered five key ligand-receptor-associated genes (Fn1, Vcam1, Fbn1, Col4a1, Col4a2), with VCAM1 prominently expressed in EC_EndMT.
  • Observed cell trajectory shifts towards EC_EndMT and subsequent changes during diabetes progression.
  • GSEA indicated that VCAM1 upregulation may inhibit cell growth and energy metabolism.

Conclusions:

  • Endothelial cell subtype EC_EndMT plays a complex role in diabetes-related neurodegenerative diseases.
  • VCAM1 is implicated in the dysregulation of EC_EndMT biological functions via cell-cell communication.
  • Quercetin shows potential as a therapeutic agent targeting VCAM1, as predicted by molecular docking.